Gilead Sciences Inc.

NAS : GILD
Pharmaceuticals
Foster City California
2011 Revenue (US$ Millions)$8,385
2010 Revenue (US$ Millions)$7,949
Revenue Growth (%)5.48%
Net Income (US$ Millions)$2,804
Common Shares Outstanding (Millions)$753
Earnings Per Share (US$)$3.55
Earnings Per Share Growth (%)6.93%
Price To Earnings Ratio11.94
Total Equity (US$ Millions)$6,739
Profit Growth (%)-3.36
Profit Margin (%)33.43%
Return On Equity (%)47.81%
Long Term Debt (US$ Millions)$7,753
Debt To Equity Ratio (%)1.15%
Market Capitalization (US$ Millions)$30,825
Total Assets (US$ Millions)$17,303
Return on Assets (%)24.18
Current Assets (US$ Millions)$13,919
Inventories (US$ Millions)$1,390
Current Liabilities (US$ Millions)$2,515
Cost of Goods Sold (US$ Millions)$2,124
Asset Turnover0.48
Inventory Turnover1.64